Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Market Cap	58.29B -22.7%
Revenue (ttm)	117.19B +5.8%
Net Income	5.51B -80.2%
EPS	465.19 -79.0%
Shares Out	12.91M
PE Ratio	9.71
Forward PE	n/a
Dividend	150.00 (3.19%)
Ex-Dividend Date	Dec 29, 2025

Volume	46,000
Average Volume	63,047
Open	4,580.00
Previous Close	4,630.00
Day's Range	4,555.00 - 4,755.00
52-Week Range	4,350.00 - 6,890.00
Beta	0.23
RSI	40.22
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1971
• Employees: 220
• Stock Exchange: KOSDAQ
• Ticker Symbol: 007370

Financial Performance

In 2024, Jin Yang Pharmaceutical's revenue was 113.33 billion, an increase of 20.94% compared to the previous year's 93.71 billion. Earnings were 29.69 billion, an increase of 140.63%.